AI assistant
USCOM LIMITED — Board/Management Information 2009
Dec 15, 2009
65979_rns_2009-12-15_7ccca278-5c64-499e-9d4d-c0cd10651258.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Uscom Limited ABN 35091028090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au
M A R K E T A N N O U N C E M E N T
World Hemodynamics Expert Joins USCOM Medical Advisory Board
Wednesday 16th December 2009: Uscom (ASX code: UCM) today announced the appointment of Professor David Bennett of St Thomas’ Hospital in London to the Uscom Medical Advisory Board. The appointment follows recent assessments of the USCOM technology at St Thomas’ Hospital.
Professor Bennett has a 30 year association with Doppler technology and is an acknowledged world expert in cardiovascular monitoring and the Editor of the Cardiology section of Critical Care, one of the leading international journals of critical care medicine. Professor Bennett’s contribution to the Medical Advisory Board will include the guidance of clinical research and new product developments.
Rob Phillips, the Executive Chairman of Uscom and Director of Clinical Science said “Professor Bennett has a long standing interest in Doppler ultrasound and is an influential thinker in cardiovascular monitoring being recognised globally for his work in the technology of circulation and circulatory management. Professor Bennett’s expertise in adult Intensive Care will compliment the other specialities represented on the Uscom Medical Advisory Board including Paediatric Intensive Care, Anaesthesia, Hypertension, Heart Failure, Cardiopulmonary medicine, and Cardiac Pacing.”
Mr Paul Butler, the Uscom CEO said “This is an excellent appointment for Uscom as Professor Bennett has extensive experience in cardiovascular monitoring over a long period and has been instrumental in the evaluation and adoption of a number of new technologies. His commitment to Uscom comes at a particularly exciting time as we accelerate our European sales focus through the Spacelabs partnership.”
Professor Bennett was director of Intensive care at St George's Hospital in London for 30 years, during this time he has been engaged in techniques for monitoring and managing the circulation particularly in high risk surgical patients. He continues to maintain this interest as an honorary consultant physician to St Thomas' Hospital in London and Visiting Professor to Kings College, London.
About Uscom
Uscom Limited is an Australian medical device company which was first listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor. The USCOM is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency Medicine, Intensive Care Units and Anesthesia, and is a tool of choice for management of adult and paediatric sepsis, and for the guidance of all fluid administration. USCOM has global regulatory approval and the technology is currently marketed in North America, South America, Europe, the Middle East, India and Australia by Spacelabs Healthcare, while in China and SE Asia USCOM is distributed by Pacific Medical Systems and in New Zealand it is distributed by MedXus.
Uscom Contacts
Paul Butler Chief Executive Officer [email protected]
Rob Phillips Executive Chairman [email protected]